assembly_id	genome_id	genome_def	crispr_array_locus_merge	crispr_array_location_merge	crispr_locus_id	crispr_pred_method	array_in_prot	prot_within_array_20000	prot_in_genome	crispr_type_by_cas_prot	consensus_repeat	repeat_length	self-targeting_spacer_number	self-targeting_target_number	spacer_location	protospacer_location	repeat_type	spacer_locus_num	spacer_num	correct_crispr_type	genome_cas_prots	unknown_protein_around_crispr	L10	L10_domain	L9	L9_domain	L8	L8_domain	L7	L7_domain	L6	L6_domain	L5	L5_domain	L4	L4_domain	L3	L3_domain	L2	L2_domain	L1	L1_domain	R1	R1_domain	R2	R2_domain	R3	R3_domain	R4	R4_domain	R5	R5_domain	R6	R6_domain	R7	R7_domain	R8	R8_domain	R9	R9_domain	R10	R10_domain
GCF_001971785.1_ASM197178v1	NZ_CP019389	Seonamhaeicola sp. S2-3 chromosome, complete genome	1	3561886-3565877	1,1,2	CRISPRCasFinder,PILER-CR,PILER-CR	no	cas2,cas1,cas9	DEDDh,cas3,csa3,RT,PrimPol,cas2,cas1,cas9	 Type II-B,Type II-A,Type II-B,Type II-C, or Type II-C?	GTTGTGAATTGCTTTCAGTTCTTTAAATTTATGGATGATTCACAGG,GTTGTGAATTGCTTTCAGTTCTTTAAATTTATGGATGATTCACAGG,GTTGTGAATTGCTTTCAGTTCTTTAAATTTATGGATGATTCACAGG	46,46,46	0	0	NA	NA	NA:NA:NA	52,26,26	52	TypeII-B,TypeII-A,TypeII-B,TypeII-C,orTypeII-C?	DEDDh,cas3,csa3,RT,PrimPol,cas2,cas1,cas9	NA|113aa|up_4|NZ_CP019389.1_3559030_3559369_+,NA|100aa|up_1|NZ_CP019389.1_3561222_3561522_-,NA|62aa|up_0|NZ_CP019389.1_3561550_3561736_+,NA|174aa|down_8|NZ_CP019389.1_3580776_3581298_+	NA|298aa|up_9|NZ_CP019389.1_3552819_3553713_+	cd08420, PBP2_CysL_like, C-terminal substrate binding domain of LysR-type transcriptional regulator CysL, which activates the transcription of the cysJI operon encoding sulfite reductase, contains the type 2 periplasmic binding fold	NA|212aa|up_8|NZ_CP019389.1_3553944_3554580_+	cd03016, PRX_1cys, Peroxiredoxin (PRX) family, 1-cys PRX subfamily; composed of PRXs containing only one conserved cysteine, which serves as the peroxidatic cysteine	NA|601aa|up_7|NZ_CP019389.1_3554601_3556404_+	TIGR01931, Sulfite_reductase_flavoprotein_alpha-component, sulfite reductase [NADPH] flavoprotein, alpha-component	NA|566aa|up_6|NZ_CP019389.1_3556439_3558137_+	PRK13504, PRK13504, NADPH-dependent assimilatory sulfite reductase hemoprotein subunit	NA|126aa|up_5|NZ_CP019389.1_3558448_3558826_+	cd08916, TrHb3_P, Truncated hemoglobins (TrHbs, 2/2Hb, 2/2 globins); group 3 (P)	NA|113aa|up_4|NZ_CP019389.1_3559030_3559369_+	NA	NA|381aa|up_3|NZ_CP019389.1_3559559_3560702_+	PRK13260, PRK13260, 2,3-diketo-L-gulonate reductase; Provisional	NA|67aa|up_2|NZ_CP019389.1_3561025_3561226_+	pfam01129, ART, NAD:arginine ADP-ribosyltransferase	NA|100aa|up_1|NZ_CP019389.1_3561222_3561522_-	NA	NA|62aa|up_0|NZ_CP019389.1_3561550_3561736_+	NA	cas2|115aa|down_0|NZ_CP019389.1_3566665_3567010_-	COG3512, COG3512, CRISPR-associated protein, Cas2 homolog [Defense mechanisms]	cas1|301aa|down_1|NZ_CP019389.1_3567043_3567946_-	TIGR03639, cas1_NMENI, CRISPR-associated endonuclease Cas1, subtype II/NMENI	cas9|1810aa|down_2|NZ_CP019389.1_3567949_3573379_-	pfam18541, RuvC_III, RuvC endonuclease subdomain 3	NA|207aa|down_3|NZ_CP019389.1_3573814_3574435_-	TIGR00057, Putative_threonylcarbamoyl-AMP_synthase, tRNA threonylcarbamoyl adenosine modification protein, Sua5/YciO/YrdC/YwlC family	NA|321aa|down_4|NZ_CP019389.1_3574580_3575543_+	cd05483, retropepsin_like_bacteria, Bacterial aspartate proteases, retropepsin-like protease family	NA|323aa|down_5|NZ_CP019389.1_3575539_3576508_+	cd02859, E_set_AMPKbeta_like_N, N-terminal Early set domain, a glycogen binding domain, associated with the catalytic domain of AMP-activated protein kinase beta subunit	NA|777aa|down_6|NZ_CP019389.1_3576514_3578845_-	TIGR01073, ATP-dependent_DNA_helicase_PcrA, ATP-dependent DNA helicase PcrA	NA|521aa|down_7|NZ_CP019389.1_3579201_3580764_+	cd02808, GltS_FMN, Glutamate synthase (GltS) FMN-binding domain	NA|174aa|down_8|NZ_CP019389.1_3580776_3581298_+	NA	NA|305aa|down_9|NZ_CP019389.1_3581299_3582214_-	pfam01734, Patatin, Patatin-like phospholipase
